Mark W. Riemen

621 total citations
17 papers, 509 citations indexed

About

Mark W. Riemen is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mark W. Riemen has authored 17 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Mark W. Riemen's work include Chemical Synthesis and Analysis (7 papers), Cancer-related gene regulation (5 papers) and Virus-based gene therapy research (4 papers). Mark W. Riemen is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Cancer-related gene regulation (5 papers) and Virus-based gene therapy research (4 papers). Mark W. Riemen collaborates with scholars based in United States. Mark W. Riemen's co-authors include Allen Oliff, James P. Tam, R. B. Merrifield, V M Garsky, Ronald Wegrzyn, Deborah Defeo-Jones, Gerald A. Vuocolo, David Heimbrook, J Y Tai and Hidesaburô Hanafusa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Mark W. Riemen

17 papers receiving 474 citations

Peers

Countries citing papers authored by Mark W. Riemen

Since Specialization

Citations

This map shows the geographic impact of Mark W. Riemen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Riemen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Riemen more than expected).

Fields of papers citing papers by Mark W. Riemen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Riemen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Riemen. The network helps show where Mark W. Riemen may publish in the future.

Co-authorship network of co-authors of Mark W. Riemen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Riemen. A scholar is included among the top collaborators of Mark W. Riemen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Riemen. Mark W. Riemen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Mechanisms of aspartimide formation: the effects of protecting groups, acid, base, temperature and time. 1992 ·PubMed ·James P. Tam, Mark W. Riemen, R. B. Merrifield	45
2	A Cloned Gene for Human Transferrin 1991 ·Annals of the New York Academy of Sciences ·Charles L. Hershberger, (unknown), (unknown), Paul R. Rosteck, Paul Williams, Bradley S. DeHoff, P.P.J. Dunn, (unknown), Mark W. Riemen, (unknown), (unknown), Jelena Ivančić-Jelečki	22
3	Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. 1990 ·Journal of Biological Chemistry ·Raymond E. Jones, Ronald Wegrzyn, Denis R. Patrick, (unknown), Gerald A. Vuocolo, Mark W. Riemen, Deborah Defeo-Jones, V M Garsky, David Heimbrook, Allen Oliff	73
4	Substitution of Lysine for Arginine at Position 42 of Human Transforming Growth Factor-α Eliminates Biological Activity without Changing Internal Disulfide Bonds 1989 ·Molecular and Cellular Biology ·Deborah Defeo-Jones, J Y Tai, Gerald A. Vuocolo, Ronald Wegrzyn, Timothy Schofield, Mark W. Riemen, Allen Oliff	1
5	Spontaneously Transformed NRK Cells Lose Their Mitogenic Response to Epidermal Growth Factor 1989 ·Growth Factors ·Ronald Wegrzyn, Deborah Defeo-Jones, David Heimbrook, (unknown), DAVID M. KIEFER, Mark W. Riemen, Allen Oliff	1
6	Minimal antiproliferative effect of recombinant müllerian inhibiting substance on gynecological tumor cell lines and tumor explants. 1989 ·PubMed ·(unknown), Richard L. Cate, DAVID M. KIEFER, Mark W. Riemen, Diego Stéfani T. Martinez, Robert M. Hoffman, Patricia K. Donahoe, Daniel D. Von Hoff, Blake Pepinsky, (unknown)	35
7	Substitution of lysine for arginine at position 42 of human transforming growth factor-alpha eliminates biological activity without changing internal disulfide bonds. 1989 ·Molecular and Cellular Biology ·Deborah Defeo-Jones, J Y Tai, Gerald A. Vuocolo, Ronald Wegrzyn, (unknown), Mark W. Riemen, Allen Oliff	35
8	Minimal ligand analysis of gastrin releasing peptide. Receptor binding and mitogenesis. 1988 ·Journal of Biological Chemistry ·David Heimbrook, (unknown), V M Garsky, (unknown), DAVID M. KIEFER, Allen Oliff, Mark W. Riemen	36
9	Structure-Function Analysis of Synthetic and Recombinant Derivatives of Transforming Growth Factor Alpha 1988 ·Molecular and Cellular Biology ·Deborah Defeo-Jones, J Y Tai, Ronald Wegrzyn, Gerald A. Vuocolo, Audrey Baker, Linda S. Payne, Victor M. Garsky, Allen Oliff, Mark W. Riemen	4
10	Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha. 1988 ·Molecular and Cellular Biology ·Deborah Defeo-Jones, J Y Tai, Ronald Wegrzyn, Gerald A. Vuocolo, Audrey Baker, Linda S. Payne, V M Garsky, Allen Oliff, Mark W. Riemen	50
11	Isolation of multiple biologically and chemically diverse species of epidermal growth factor 1987 ·Peptides ·Mark W. Riemen, Ronald Wegrzyn, Audrey Baker, William M. Hurni, Carl D. Bennett, Allen Oliff, Robert B. Stein	15
12	Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor. 1987 ·Proceedings of the National Academy of Sciences ·Susan H. Socher, Mark W. Riemen, D. Martínez, Arthur Friedman, J. Tai, J C Quintero, V M Garsky, Allen Oliff	35
13	Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus 1987 ·Virology ·Paul M. Keller, Andrew J. Davison, Robert S. Lowe, Mark W. Riemen, Ronald W. Ellis	28
14	Preparation of semisynthetic insulin analogs from bis(tert-butyloxycarbonyl)-desoctapeptide-insulin phenylhydrazide: importance of the aromatic region B24-B26 1983 ·Biochemistry ·Mark W. Riemen, Liza A. Pon, Frederick H. Carpenter	17
15	Cyclohexyl ester as a new protecting group for aspartyl peptides to minimize aspartimide formation in acidic and basic treatments 1979 ·Tetrahedron Letters ·James P. Tam, (unknown), Mark W. Riemen, (unknown), R. B. Merrifield	58
16	gag-Related polypeptides encoded by replication-defective avian oncoviruses 1979 ·Journal of Virology ·Carl W. Rettenmier, Steven M. Anderson, Mark W. Riemen, Hidesaburô Hanafusa	36
17	Averaging of φ₂ and φ₃ in [5‐leucyl]‐enkephalin 1978 ·FEBS Letters ·Alan J. Fischman, Mark W. Riemen, David Cowburn	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact